Table 3.

Pairwise Comparison of Mean Ranks of Onset and Lasting Times for Post-COVID-19 Vaccination Signs and Symptoms by Dose.

Vaccine Name	Onset Time		Lasting Time
	FD MR	SD MR	FD MR	SD MR
Sinopharm and Covaxin	618.57–629.79	623.28–708.51 *	635.98–750.91	590.76–765.92 **
Sinopharm and Sputnik V	618.57–748.20 **	623.28–681.50 *	635.98–784.13 **	590.76–758.98 **
Sinopharm and Oxford AstraZeneca	618.57–915.52 **	623.28–925.58 **	635.98–880.52 **	590.76–849.78 **
Sinopharm and COVIran Barekat	618.57–957.35 **	623.28–1000.85 **	635.98–475.75 *	590.76–621.72
Covaxin and Sputnik V	629.79–748.20 *	708.51–681.50	750.91–784.13	765.92–758.98
Covaxin and Oxford AstraZeneca	629.79–915.52 **	708.51–925.58 **	750.91–880.52 *	765.92–849.78
Covaxin and COVIran Barekat	629.79–957.35 **	708.51–1000.85 **	750.91–475.75 **	765.92–621.72
Sputnik V and Oxford AstraZeneca	748.20–915.52 **	681.50–925.58 **	784.13–880.52 *	758.98–849.78 *
Sputnik V and COVIran Barekat	748.20–957.35 **	681.50–1000.85 **	784.13–475.75 **	758.98–621.72 *
Oxford AstraZeneca and COVIran Barekat	915.52–957.35	925.58–1000.85	880.52–475.75 **	849.78–621.72 **

MR: mean rank; FD: first dose; SD: second dose; * Kruskal–Wallis p-value < 0.05; ** Kruskal–Wallis p-value < 0.001.